High-risk groups such as medical personnel and airport staff
General public, including children and the elderly
SARS-CoV-2 infects humans primarily through the oral mucosa, making the oral cavity a crucial entry point for viral invasion. The team developed the "Jieyuan Herbal Oral Cleansing Solution," featuring natural herbal components such as theaflavins. Utilizing specialized extraction technology, the product effectively suppresses the expression of viral receptors (ACE2 and TMPRSS2) in oral mucosal cells and blocks the binding of SARS-CoV-2 spike protein to these receptors. Clinical studies have validated the product's safety and efficacy across multiple SARS-CoV-2 variants, particularly the Omicron strain.
Unique herbal mechanism inhibiting viral receptor expression
Low-temperature extraction technology preserving high purity and activity
Effective against multiple variants, including Omicron
Over 3,000 clinical service cases accumulated
Over 17,000 packets of the product prepared and sold
Prevention rate of approximately 94.14% among hospital staff
Significant reduction in ACE2 expression in oral mucosa
Blocks binding of viral spike protein to receptors
Significantly reduced infection risk for co-living contacts in dormitories
No adverse reactions or side effects in human clinical trials
Non-toxic confirmed by cell and animal experiments
Adverse event rate less than 0.001%
User satisfaction rate over 95%
Most users willing to continue use and recommend to others
High acceptance among medical staff and the general public
Published 7 SCI international journal papers
Published in Biomedicine & Pharmacotherapy journal
Awarded the 18th, 19th, 21th National Innovation Award (Clinical Innovation)
Provides an innovative oral protection strategy beyond vaccines
Establishes an evidence-based model for scientific TCM epidemic prevention
Reduces cluster infection risks and enhances public health benefits
